Cardiovascular Toxicology

SJR Rank #5,757H-index: 70SJR: 0.903Best quartile: Q2APC: US$4,890
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Cardiology and Cardiovascular MedicineQ2
  • Molecular BiologyQ2
  • ToxicologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Chemotherapy-induced cardiotoxicity and mitigationCardiac electrophysiology and arrhythmiasCardiac Ischemia and ReperfusionAir Quality and Health ImpactsIon channel regulation and functionCardiovascular Function and Risk FactorsCancer Treatment and PharmacologyHeavy Metal Exposure and ToxicityTrace Elements in HealthPoisoning and overdose treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs060120180240

Documents per Year

2022202503570105140

Detailed Information

ISSN

1530-7905, 1559-0259

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

3.53

References per Document

63.13

Coverage

2001-2026

Scope

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on toxicological aspects of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs.

Metrics from SCImago Journal Rank 2025. View on SCImago